Asia Pacific
Showing 12 of 12
Australia
GST recovery opportunities worth millions go unclaimed every year. Our TGA expertise ensures you capture every available saving while maintaining seamless compliance across this regional powerhouse.
Thailand
Navigate Thailand’s FDA requirements and capitalize on the country’s strategic Southeast Asian location while managing tropical climate challenges.
Taiwan
Advanced healthcare infrastructure meets complex cross-strait logistics challenges. TFDA compliance becomes your competitive advantage when backed by our specialized customs and regulatory expertise.
South Korea
Experience the highest clinical trial growth rates in Asia-Pacific with confidence. K-FDA’s strict documentation standards become manageable with our deep understanding of Korean regulatory culture and business protocols.
Vietnam
Emerging opportunities in one of Asia’s fastest-developing markets. DAV regulatory frameworks and infrastructure challenges transform into competitive advantages with our comprehensive market expertise.
Singapore
World-class logistics infrastructure deserves world-class regulatory support. HSA excellence meets our proven efficiency standards, making Singapore your gateway to Southeast Asian clinical success.
Philippines
Archipelago logistics complexity meets emerging market potential. FDA Philippines requirements become manageable stepping stones to accessing one of Asia’s most promising clinical research markets.
New Zealand
Medsafe’s streamlined processes offer speed advantages in the Pacific market. We help you capitalize on New Zealand’s efficient regulatory environment while managing unique geographic logistics challenges.
Malaysia
Multicultural advantages and NPRA processes combine to create unique opportunities. We optimize Malaysia’s position as your regional distribution hub while ensuring seamless regulatory compliance.
China
Our proven track record meets NMPA’s evolving framework in the world’s second-largest pharmaceutical market. We transform complex import procedures into streamlined pathways for breakthrough treatments.
Japan
PMDA’s rigorous processes demand more than regulatory knowledge, they require cultural fluency. We bridge traditional business protocols with modern clinical trial efficiency in Asia’s most established market.
India
Massive patient populations across diverse states create unparalleled opportunities and intricate regulatory variations. CDSCO frameworks are simplified through our comprehensive understanding of India’s complex landscape.
World-Class Import Structuring Can Transform Your Clinical Trial
Surely that’s worth a conversation?